Spectrophotometric Determination of Pantoprazole Sodium in Pharmaceuticals Using N-Bromosuccinimide, Methyl Orange and Indigo Carmine as Reagents

Document Type: Research Article

Authors

1 Department of Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, INDIA

2 Process Analytical Laboratory, Advinus Therapeutics, Peenya, II Phase, Bangalore-58, INDIA

Abstract

Two sensitive spectrophotometric methods are presented for the assay of pantoprazole sodium sesqui hydrate (PNT) in bulk drug and in formulations using N-bromosuccinimide (NBS) and two dyes, methyl orange and indigo carmine, as reagents. The methods involve the addition of a known excess of NBS to PNT  in acid medium, followed by determination of unreacted oxidant by reacting with a fixed amount of either methyl orange and measuring the absorbance at 520 nm (method A) or indigo carmine and measuring the absorbance at 610 nm (method B). In both methods, the amount of NBS reacted corresponds to the amount of PNT and  the measured absorbance is found to increase linearly with the concentration of PNT  which is corroborated by the correlation coefficients of 0.9959 and 0.9985 for method A and method B, respectively. The systems obey Beer’s law for 0.1 - 2.0 mg mL-1 and 0.5 - 6.0 mg mL-1 for method A and method B, respectively. The limits of detection and quantification are also reported for both methods. Intra-day and inter-day precision, and accuracy of the methods have been evaluated. The methods were successfully applied to the assay of PNT in tablet preparations and the results were statistically compared with those of the reference method by applying Student’s t-test and F-test. No interference was observed from the common tablet excipients. The accuracy of the methods was further ascertained by performing recovery studies via standard-addition method.

Keywords

Main Subjects


[1] The  Merck  index,  12th  Ed.,  Merck  and  Co.  Inc., White House Stations, NJ, pp. 1205 (1997).
[2] Current Index of Medical Specialities (CIMS),  CMP Medica India Pvt Ltd., Bangalore, India, July-October, pp. 76 (2005).
[3] Ding, G., Tang, A., Wang, J., Cong, R. and Bao, J., Direct Enantioseparation of Pantoprazole Sodium by High Performance Liquid Chromatography on Teicoplanin-Bonded Chiral Stationary Phase, Sepu., 24, 46 (2006), 2006 ACS on Scifinder; CAN 144:199119; AN 2006:141860.
[4] Ding, G., Cong, R., and Wang, J., Direct Enantio Separation of Pantoprazole Sodium by High Performance Liquid Chromatography, Sepu., 22, 241 (2004), 2006 ACS on Scifinder; CAN 141:59853; AN 2004:563455.
[5] Xue-Hui, H. and Fu-Sheng, P., Determination of Pantoprazole Sodium in Capsules by HPLC, Zhongguo Yiyao Gongye Zazhi, 31, 502 (2000), ACS on Scifinder; CAN 134:91243; AN 2001:52063.
[6] Agbaba, D., Novovic, D., Karljikovic-Rajic, K. and Marinkovic, V., Densitometric Determination of Omeprazole, Pantoprazole, and their Impurities in Pharmaceuticals, J. Planar Chromatogr. Mod. TLC., 17, 169 (2004).
[7] Karljikovic-Rajic, K., Novovic, D., Marinkovic, V. and Agbaba, D., First-order UV-Derivative Spectrophotometry in the Analysis of Omeprazole and Pantoprazole Sodium Salt and Corresponding Impurities, J. Pharm. Biomed., Anal., 32, 1019 (2003).
[8] Wahbi Abdel-Aziz, M., Abdel-Razak, O., Gazy, A. A., Mahgoub, H., and Moneeb, M. S., Spectro-photometric Determination of Omeprazole, Lansoprazole and Pantoprazole in Pharmaceutical Formulations, J. Pharm. Biomed. Anal., 30, 1133 (2002).
[9] Salama, F., El-Abasawy, N., Razeq, S. A. A., Ismail, M. F. and Fouad, M. M., Spectrophotometric Determination of Omeprazole and Pantoprazole Sodium via Chelates with Iron, Chromium, and Cobalt, Bull. Fac. Pharm (Cairo University), 41, 185 (2003).
[10] Moustafa,  A. A. M.,  Spectrophotometric  Methods for the Determination of Lansoprazole and Panto-prazole Sodium Sesquihydrate, J. Pharm. Biomed.  Anal., 22, 45 (2000).
[11] Berka, A., Vulterin, J. and Zyka, J., Newer Redox Titrants (Pergamon Press, London) 38(1965).
[12] International  Conference  on  Hormonisation of Technical Requirements for Registration of Pharma-ceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.